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We have recently developed a model in which mice were treated with IL-4 after primary immunization,
resulting in elevated tolal serum IgGi and IgE levels, but decreased antigen-specific levels and memory
formation for these isotypes. In this report, we describe that these effects of IL-4 are mediated at the
B cell and not the T-cell level. Major changes occurred in the 7iC-double positive B-cell population which
is increased as a result of IL-4 treatment. Moreover, it is shown that 7ie-double positive B cells can
develop in vitro out of 71-positive primed B cells and that these double positive cells can differentiate into
IgGr and IgE-secreting cells. The existence of 7ie-double positive memory B cells can explain the
differences in cytokine dependence of TNP-specific memory IgGj and IgE responses found after
adoptively transferring primed spleen cells into irradiated naive recipients. Whereas the IL-4 inde-
pendent TNP-specific memory IgGi responses could be blocked efficiently by neutralizing IL-5 and
IL-6, TNP-specific memory IgE responses were virtually not susceptible to such treatment. These IgE
responses were also not susceptible to IFN-7, used in doses that could inhibit the primary IgE response.
Inhibition of the TNP-specific memory IgG 1 response by neutralizing IL-5 and IL-6 is accompanied by a
10-fold increase of the IL-4 independent TNP-specific IgE memory response. These data indicate that
secondary IgE responses primarily result from B cells that are either switched lo IgG|, or are double
positive for IgG| and IgE, thereby suggesting a minor role for e-single positive B cells in secondary IgE
responses.
R. van Ommen PhD, Department of Immunology. Erasmus University, PO Box 1738. 3000 DR
Rotterdam, The Netherlands
INTRODUCTION
Interleukin-4 (IL-4) has been found to be necessary for the
induction of IgE synthesis on account of its ability to induce
the expression of f-germline transcripts [1,2]; the inhibition of
parasite-induced IgE responses by neutralizing antibodies
against IL-4 [3]; the absence of IgE responses in nematode-
infected mice that were made IL-4-deficient by gene targeting
[4], and the IgE hyperproduction in IL-4 transgenic mice
[5-7]. Although IL-4 induces accumulation of germline
transcripts for 71 [8, 9], which correlates with an increase in
lgG|-secreting cells 110], it is nol required for IgGj synthesis
as was shown in IL-4 deficient mice 14].
Functional studies indicate that IL-4 is a 'switch inducing'
factor. It alters the chromatin structure of the S7, region [9]
and induces accumulation of germline 71 and « transcripts [1,
8,11,12]. The induction of 71 germline transcripts is inhibited
by inlerferon-7 {IFN-7) [8], which also inhibits the in vivo
production of IgG, and IgE 113]. IL-4 and IEN-7 act
reciprocally in the determination of IgG| and IgE responses
[14], whereas IL-5 seems to act synergistically with IL-4 in
that it specifically enhances the accumulation of productive 71
and e transcripts [15], IL-5 and IL-6 are both cytokines
involved in the maturation of B cells to become Ig-secreting
plasma cells [16, 17]. However, we have recently shown that
primary and secondary antigen-specific and total IgGi, but
not IgE responses are dependent on IL-6 to obtain peak levels
[18].
Like igG] responses, secondary IgE responses are partially
IL-4-independenl [18-21], although IL-4 seems to be still
important in sustaining in vivo IgE responses [22]. The
IL-4-independent component of a secondary IgE response
developed only when IL-4 was present during the primary
response [3, 19], indicating that such response was based on B
cells that have already switched to IgE. Such cells were,
although in low frequency, found after immunization and
can produce IgE upon subsequent culturing [23].
Recently, evidence for sequential isotype switching from fx
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to f. via 7i has been reported [2, 24]. This isotype switching
mechanism could explain why. during the process of switching
to IgE, many cells express both 71 and c on their membranes
[25]. It was further suggested that individual 7i€-double
positive B cells can co-secrete these two isotypes [24].
Most of the studies on the involvement of IL-4 in IgE
responses used MoAb to neutralize IL-4. However, recently
IgE regulation in IL-4 transgenic mice has been described
[5-7]. These mice are exposed to high levels of IL-4 during
development which can lead to aberrant situations. There-
fore, we used an alginate encapsulation method in which an
IL-4 producing cell line is encapsulated and subsequently
implanted in the peritoneal cavity of normal developed mice,
lo modulate in vivo IL-4 levels [19]. The aim of this study was
to investigate the effect of thus modulated IL-4 levels on the
memory formation for IgG| and IgE responses in vivo with
respect to B and T cells. It was found that the previously
observed IL-4-induced decreased antigen-specific memory
formation for IgG| and IgE [19] was mediated at the B-cell
and not the T-cell level. Flow cytometry revealed that IL-4
exerted its effect mainly on the pool of 7ie-double positive B
cells. It was found in vitro that these 7ie-double positive B
cells developed out of 7(-positive B cells. Moreover, data are
presented that suggest that 7ie-double positive B cells can
either develop into IgGi- or IgE-secreting cells, leaving open
the question of whether both isotypes are produced at the
same time by one B cell. In vivo the existence of those cells 3
months after priming is indirectly shown by differences in
cytokine requirement of memory B cells. This cytokine
dependence is not changed by IL-4 treatment during the
memory formation, indicating that IL-4 mediates its effects
on pools of B cells, not inducing intrinsic changes in B cells
leading to different cytokine requirements.
MATERIALS AND METHODS
Mic-e. Female BALB/c mice were bred and maintained at the
Department of Immunology of the Erasmus University. Al! mice
were at an age of 12-16 weeks at the start of the experiments. They
were held in light-cycled rooms and had access to acidified water and
pelleted Tood ad libitum. The microbiological status of the mice
fulfilled the standard of 'specific pathogen free V* according to the
criteria of {he Dutch Veterinary Inspection, as described In the law
on animal experiments. The experiments were approved by the
Animal Experiments Committee of the Erasmus University.
Immunization. KLH (Pierce. Rockford. IL, USA) was trinitrophe-
nylated to a level of 25 TNP residues per 10*'Da of KLH {as
determined spectrophotometrically) [26] by using trinitrobenzene-
sutphonic acid (Eastman Kodak, Rochester, NY, USA). Mice were
injected with 0.2ml containing either 10 or 100/ig TNP-KLH
adsorbed on 2mg alum i,p., as indicated in the Results section.
Cytokine treatment. Mice immunized with lOO^g TNP-KLH
adsorbed on alum were implanted i.p. with 2 x 10^  CV-i/IL-4 cells
encapsulated in alginate every 2 weeks for a period of 4 months [19,
27. 28]. The CV-I/IL-4 cells were a kind gift of Dr N. Arai (DNAX
Research institute, Palo Alto, CA, USA]. Empty beads encapsulated
in alginate were used as control. No immunological effects were
induced by this treatment in all experiments. This control is
sufficient, since it has been shown that the IL-5-producing cell line
CV-l/IL-5 encapsulated in alginate could not restore (he impaired
IgE synthesis in SJA/9 mice (data not shown). Encapsulated CV-t/
IL-4 cells in vivo produce IL-4 for a period of at least 2 weeks |28],
The lFN-') treatment consisted of two injections of 25/xg of purified
IFN-7 dialysed and diluted in PBS -1-10 mM cysteine per day on days
1-5 of the primary response. During the secondary response two
injections of 40^g per day were given i.p. on days 1-3.
Adoptive transfer of spleen cells. Spleens of control-treated and IL-
4 treated mice were removed under aseptic conditions and single cell
suspensions were prepared. Then 1 x 10 spleen cells were trans-
ferred via the tail vein into naive recipients. The recipients had been
sublethally irradiated (6 Gy) with a caesium-137 source (Gamma-cell
40, Atomic Energy of Canada. Ottawa, Canada) I day before cell
transfer. All reconstituted mice were i.p. immunized with 10 /lg TNP-
KLH adsorbed on alum immediately after transfer.
Anti-cytokine treatment. Mice were treated in vivo by i.p. injection
of neutralizing antibodies directed to lL-4 (1IBI1. rat IgG|, lOmg/
mouse) [29], IL-5 (TRFK-5, rat IgG,. 2mg/mouse) [30]. IL-6 (20F3.
rat IgGi, 2mg/mouse) [31], IFN-7 (XMG1.2. rat IgG,, lOmg/
mouse) [32], alone or in combination. Rat MoAb specific for E.
coli /?-galactosidase (GL1I3) [27] was used as an IgGi isotype
control. The MoAb were purified from culture supernatants by
protein G affinity chromatography [33], These doses of antibody
have been widely shown to be sufficient to neutralize the respective
cytokine activities In a variety of systems.
Isotype-specific ELISA. Total serum IgE, IgGi and IgGja. levels
were measured by isotype-specific ELISA as described previously
[19. 34]. Detection limits for the IgE. IgG, and lgGj^ ELISA were
0.5 ng/ml, 0.2 ng/ml and 0.3mg/ml. respectively. TNP-specific lgG|
and IgE serum levels were determined as previously described [19],
with 0.2 ng/ml and 1 ng/ml as respective detection limits in the
ELISA.
ELISA-spot assay. Nitrocellulose bottomed 96-well Multiscreen
HA plates (Millipore, Bedford. MA, USA) were coated with either
EM95 [35]. 2/ig/ml. or goat anti-mouse IgG], 1/ig/ml (Southern
Biotechnology), and blocked with PBS containing 1% BSA. The
plates were then incubated with spleen cell samples for 4 h in a
humidified and vibration free 5% COi incubator. Plates were washed
once with 0.05% Tween 20 in distilled water, to remove the cells and
twice with PBS containing 0.1% BSA and 0.05% Tween 20.
Subsequently, the plates were treated as in a normal ELISA.
Development was done by using AEC substrate which was prepared
by dissolving 25 mg of 3-amino-9-ethyl carbazole (AEC) (Sigma
Chemical, St Louis, MO, USA) in 2 ml dimethylformamide, fol-
lowed by addition of 95 m! of 0.05 M acetate buffer, pH 5.0 and 40 n\
of 30% H1O2. The substrate solution was filtered (0.2 jim) to remove
particulate matter. Developed plates were dried and the red spots
were enumerated under low magnification (lOx), using a dissecting
microscope (Stemi SV 6. Zeiss, Oberkochen, Germany) equipped
with a coaxial reflected light source.
Preparation of B cells and T cells. Splenic B cells were prepared
from control and IL-4 treated mice. T cells were cytotoxically
eliminated by treating spleen cells with anti-Thy-1.2 (clone F7D5;
Serotec. Oxford, UK) and low-tox guinea pig complement (Ceder-
lane, Hornby. Ontario, Canada) in a two-step procedure at 0 C and
iTC, respectively [36]. For the preparation of T cells, B cells and
granulocytes were eliminated by a similar procedure using anti-B220
{clone RA3-6B2) and anti-granulocyte (clone RB6-8C5). Both
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MoAb were kindly provided by Professor Dr W. van Ewijk from our
department. Viable cells were isolated by flotation on Histopaque
1119 (Sigma). The percentage of residual Thy-1 ' -cells was < 2%
and B220 ' -cells < 5% as determined by flow cytometry.
T-B cell culture. CDC35, an I-A'* restricted rabbit Ig-specific Th2
clone [37], a kind gift of Dr D. C. Parker, was maintained by
stimulation, every 2 weeks, with irradiated BALB/c spleen cells
(30 Gy) and 50/ig/ml rabbil IgG (RlgG) {Sigma) in complete
RPMI-1640 medium, supplemented with 10% heat-inactivated
FCS. 2mM glutamine. O.I M pyruvate, lOOfU/ml penicillin. 50/jg/
ml streptomycin, 50//.M 2-mercapto-ethanol and 20IU/ml IL-2. Prior
lo culture with B celts the CDC35 cells were washed and viability was
assessed by trypan blue exclusion. Routinely, viability was > 98%.
T cell-depleted spleen cells, at 2.5 x 10^  cells/ml were cultured in
eight replicate wells of flat-bottomed microtitre plates, together with
5x lo" cells/ml of irradiated CDC35 cells (30Gy) in 0.2ml of
complete RPMI-1640 medium at 5% CO2 and 37 C. The following
antigens were used for stimulation: 30ng/ml TNP-RIgG, lOng/ml
TNP-KLH+ lOng/ml RlgG. lOng/ml RlgG, lOng/ml rabbit anti-
mouse IgE (RAM/IgE) [38], or lOng/ml rabbil anti-mouse igGi
(RAM/IgG|) [39], lOng/ml rabbit anti-mouse IgG.^ .b (RAM/
lgG2u.2b) (Nordic Immunology, Tilburg, The Netherlands). These
rabbit anli-mouse isotype-specific antibodies were tested extensively
for isotype specificity. After 5 days of culture, cells were harvested for
ELISA-spol assay and supernatants for ELISA. For large-scale
experiments, essentially similar cultures were performed at 2 ml in
24-well flat-bottomed plates. On day 4 of the culture, cells were
harvested and stained for FACScan analysis.
FACScan. The cells (2.5 x lo'') were incubated on ice for 30min
with the appropriate MoAb, either as undiluted culture supernatant
ur optimally titrated purified MoAb, followed by a triple wash with
PBS containing 1 % BSA and 0.1 % azide. After using unconjugated
MoAb, another 30 min incubation was performed with a conjugated
isotype-specific second-step MoAb on ice. After a triple wash the
cells were taken up in isotonic fluid and analysed on a FACScan
analyser {Becton-Dickinson, Mountain View. CA, USA). A life gate
was used to gate out rare dead cells and erythrocytes. The following
MoAb were used for staining: biotin conjugated goat anti-mouse
IgCii (Southern Biotechnology) at 12.5/;g/ml: rat anti-mouse IgE
(Pharmingen, San Diego, CA, USA), at tO//g/ml; rat anti-mouse
B220 (clone RA3-6B2) and rat anti-mouse Thy-1 {clone 59-AD2.2).
both as undiluted culture supernatant. Rabbit anti-rat IgG, F{ab')2-
fragments FlTC-conjugated (Cappel/Organon Technika. Oss. The
Nclhcrlands, l/lOO diliiied). and R-phycoerythrin conjugated strep-
tavidin (Caltag, San Francisco. CA, USA, 1/20 diluted) were used as
second step reagents. To prevent cytophilic binding of the immunor-
eagents to FC7R, staining was performed after mild acid treatment in
the presence of 2% normal goat serum {Dako A/S, Glostrup,
Denmark). Stainings with rabbit anti-rat IgG. F(ab')2-fragments-
i-ITC conjugated (Cappel/Organon), and R-phycoerythrin conju-
gated streptavidin (Caltag) alone were used as control.
Acid treatment. To remove cytophilic bound immunoglobulin
molecules, spleen cells were treated with 0.05 M acetate buffer
(pH4.0) containing 0.085 M NaCl, 0.005 M KCI, and 1% FCS for
1 min on ice as described by Kumagai et al. |40]. To neutralize the
acid to the range of pH7.2, PBS, supplemented with 0.1 M hepes
(Gibco Life Technologies, Paisley. UK), was added to the suspen-
sion. Next the cell suspension was underlain wiih FCS. The cells were
pelleted and washed two limes with HBSS. No decrease in viability
was observed as determined by trypan blue exclusion.
Stati.stical analysis. Differences between groups were analysed
using the Student's r-test. Values of P < 0.05 were considered
significant.
RESULTS
IL-4 inhibits memory formation of TNP-KLH-specific B cells
but not T cells
In a previous study we have shown that prolonged IL-4
treatment induced decreased TNP-specific IgG| and IgE
responses after primary immunization, accompanied by a
decreased memory formation for these two isotypes [19]. In
order to determine whether IL-4 exerted this inhibitory effect
on the TNP-KLH-specific B cells, T cells or both, we
reconstituted irradiated mice with TNP-KLH-primed B
cells from control-treated mice and TNP-KLH-primed T
cells from IL-4 treated mice and vice versa. The B cells
(>98% B220^ cells) and T cells (> 95% Thy-I ' cells)
were isolated 3 months after the last of 10 IL-4 or control
administrations, to exclude direct effects of exogenous IL-4,
for it is to be expected that no exogenous IL-4 is produced by
this time. Furthermore, at this time no differences were found
in the percentages and numbers of T and B cells between
control and IL-4 treated mice (data not shown).
Irradiated control mice reconstituted with primed B cells
from IL-4 treated mice displayed, after immunization with
TNP-KLH, significantly lower TNP-specific igG, and IgE
levels when compared to mice reconstituted with primed B
cells from control mice. These levels were not influenced by
using T cells from either control or IL-4 treated mice (Fig. 1).
Apparently, T cells from lL-4 treated mice were not able lo
inhibit or amplify memory B cells from control treated mice
to give rise to TNP-specific IgG] or IgE production. More-
over, T cells from control mice failed to amplify the induction
of TNP-specific B cells from IL-4-treated mice to produce
TNP-specific IgG) or IgE levels comparable to those of
control treated mice.
These results suggest that IL-4 exerted its inhibitory
effect on the TNP-specific memory formation for IgG| and
IgE at the B cell level, not influencing the memory T cell
development.
'y/f-Douhle positive B cells are increased in IL-4 treated mice
after 10 IL-4 administrations
To study the effect at the B cell level more precisely, we
examined the number of switched B cells in the spleens of
control- and IL-4-treated mice by FACScan analysis. At days
2 and 3 after the last of 10 administrations the numbers and
percentages of 71-singie, F-single and 7if-double positive B
cells were determined (Table I). On these two days only the
number of 7ie-double positive B cells were significantly
increased (two-fold) in the lL-4-treated mice when compared
with control mice. No major differences were seen when
comparing the number of 71-single or f-single positive B
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Fig. 1. Irradiated mice (6Gy) were reconstituted with combinations or4 x 10* purified B cells and 4 x 10^  purified T cells from control
and IL-4 treated mice as indicated. All reconstituted mice were boosted with lO/ig TNP-KLH al day 0. TNP-specific i g d and IgE serum
levels were determined at day 9. Results are represented as arithmetic mean ± SEM (w = 4-6), TNP-specific I g d is expressed in mg/ml
and TNP-specific IgE is expressed in/^g/ml.
cells in the spleens of IL-4 treated tnice and control mice at
days 2 and 3 after the last of 10 administrations. Both in
control and IL-4 treated mice, 40% of the 7[-positive B cells
in the spleen were also /z-positive {data not shown).
These results show that IL-4 treatment caused its effect
mainly by increasing the pool of 7]e-double positive B cells.
')it-Double positive B cells can develop in either IgGj- or IgE-
secreting cells
To investigate whether the increase in 7ie-double positive B
cells would result In increased numbers of IgGp and IgE-
secreting cells after isotype-specific stimulation, we used a
cognate T-B cell culture system [37]. In this system T cell-
depleted splenocytes from control and IL-4-treated mice were
stimulated wilh antigen and CDC35 cells, a Th2 cell line
specific for rabbit IgG (RlgG). In this culture system rabbit
anti-mouse IgE (RAM-IgE), and rabbit anti-mouse IgGi
(RAM-IgGi) were used to selectively stimulate f- and -yr
positive B celts through their membrane-bound isotypes.
TNP coupled to RlgG (RlgG-TNP) was used to stimulate
TNP-specific B cells, whereas TNP-KLH and RlgG served as
controls for the in vitro stimulation. Both TNP-KLH and
RlgG were used as a control because stimulation by these two
antigens gave a measurement of non-cognate activation of B
cells in this system.
In all experiments this non-cognate activation leading to
i-and IgE-producing cells at day 5 of the culture gave rise
Table I. Number of switched B cells in spleens of control and IL-4 treated mice
Surface Ig expression
Control-treated
Day 2
58740 (53)
178 (0.2)
4450 (4.0)
Day 3
69300 (63)
59 {O.I)
5742 (5.2)
IL-4-treated
Day 2
59500 (54)
85(0.1)
8500 (7.7)
Day 3
89600 (60)
51(0.1)
8192(5.5)
71-single
f-single *
Surface marker expression evaluated by FACScan analysis of total spleen cells from control and IL-4-treated mice at days 2 and 3 after the
last of 10 alginate administrations. Cell suspensions were pooled from two mice. Rare dead cells and erythrocytes were gated out. Results are
the absolute number of positive cells (thousands). Number of lymphocytes per spleen based on the forward scatter/ side scatter plot were
I.I X lO" in control mice both on days2and3. In spleens oflL-4 treated mice the number oflymphocytes were 1.1 x I0^andl,5x 10** on days
2 and 3, respectively. Numbers in parentheses represent percentage of lymphocytes.
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to less than 3% of the number of IgGi- or IgE-producing cells
that developed after specific stimulation. Addition of IL-4
(100 IU/ml) to the cultures resulted in a two-fold increase of
this non-cognate activation (data not shown). Moreover,
addition of IL-4 failed to increase the number of IgGp and
igE-secreting cells after 5 days of culture, when compared
with the situation in which no IL-4 was added (data not
shown). This indicated that the CDC35 cells themselves
produced enough IL-4 after cognate stimulation to give rise
to IgG|- and IgE-secreting cells.
Kinetic studies had shown that a culture period of 5 days
was optimal for the development of IgGi- and IgE-secreting
cells, when B cells were used from primed mice (data not
shown), After 5 days of culture the numbers of IgG|-and IgE-
secreting cells, were determined by ELISA-spot assay. Results
representative for two experiments showed that upon stimu-
lation of T cell-depleted spleen cells, from IL-4 treated mice
with the Th2 cell line in the presence of RAM-IgGi, more
than twice as many IgG i-secreting cells were formed, as
compared to the situation in which splenic B cells from
control treated mice were used (Fig. 2C). A similar increase
was seen when RAM-IgE was used as antigen in these
cultures (Fig. 2C). That these differences were not caused
by an increased proliferation of T cell depleted spleen cells
from IL-4 treated mice is shown in Fig. 2A. The number of
IgE-secreting cells was dramatically increased when spleen
cells were used from mice treated with IL-4 in combination
with RAM-IgE and. to a lesser extent with RAM-IgG|, as
antigen (Fig. 2B). These data suggested an increase in B cells
already switched to IgG| (more than two-fold) and IgE
(seven-fold) as a result of prolonged IL-4 treatment.
When rabbit anti-mouse lgG2a/2b (RAM-IgG2u/2b) was
used as stimulating antigen, 5585 IgG|- and 288 IgE-secret-
ing cells per culture of T-cell depleted spleen cells of control
treated mice on day 5 were found. Upon culturing T cell-
depleted spleen cells of IL-4-treated mice with RAM-IgG2a/
2h. 4296 IgG|- and 169 IgE-secreting cells per culture were
found on day 5. This result makes clear that the observed
differences in IgG i - and IgE-secreting cells were not caused by
anti-Ig reactivity or FcR-mediated effects of RAM-IgG] and
RAM-IgE. In that case, similar increases would have been
found upon culturing with RAM-lgG2a/2b-
The increase in IgG|- and IgE-secreting cells is supported
by the cumulative immunoglobulin levels produced during
5 days of culture. When stimulating f-positive B cells in the
pool of T cell-depleted spleen cells from control mice, using
RAM-IgE, 56ng/ml of IgE was produced. During the same
period cells from IL-4 treated mice produced 217ng/ml IgE
(Table 2). As a result of the IL-4 treatment, an increase in the
IgG| production was also seen when the 71-positive B cells of
the T cell-depleted spleen cells were stimulated with RAM-
IgG| (19/ig/ml when cells were used from control mice and
29jug/ml when cells were used from IL-4 treated mice) (Table
2). Only marginal increases of IgG2a production were found
when T cell-depleted spleen cells from IL-4-treated mice
instead of from control treated mice were stimulated with
RAM-IgG, or RAM-IgE (Table 2). Addition of IL-4 to the
cultures did not markedly increase the production of the
measured isotypes (Table 2).
Collectively, these results point to a 7ie-double positive B-
cell population that can produce both IgGj and IgE upon
stimulation via their isotype. and that is increased as result of
IL-4 treatment.
-yi-Positive secondary B cells can undergo sequential isotype
switching to -yit-positive B cells
We next studied whether 7]C-doubIe positive B cells, also
developed during the in vitro T-B cell cultures, as well as
in vivo. Therefore, we examined, by flow cytometry, the
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Fig. 2. IL-4 treatment increases the number of B cells switched to
[gE and IgG, in the spleen, as compared to control mice. T cell-
depleted spleen cells were cultured with irradiated (30 Gy) CDC35
cells in the presence of either 30ng/ml TNP-RIgG, lOng/ml RAM-
IgE or lOng/ml RAM-lgGj. The total number of cells per culture
(average number per eight pooled wells of 200/il) at day 5 (A).
The dashed line indicates the maximum number of cells in cultures
stimulated with TNP-KLH and RIgG (A). The numbers of (B)
IgE-producing cells and (C) IgGi-producing cells, per culture
(average number per eight pooled wells of 200/il) were determined
at day 5.
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percentage of switched B cells in the pool of B220^ cells at
days 0 and 4 upon culturing in the presence of antigen and
CDC35 cells (Table 3). To rule out a significant contribution
of cytophyllic IgGi or- IgE to the estimation of the percentage
of 7i-positive and t-positive cells, cells were treated with acid
before staining. This procedure has previously shown to
remove all cytophilically FcR bound isotypes [40].
Moreover, all stainings were carried out in the presence of
2 % nonnal goat serum, to prevent aspecific cytophillic
binding of the immunoreagents to FC7R. At day 0 the
percentages of e-positive, 71-positive and 7rf-double positive
B cells were determined, and these cells were stimulated with
RAM-IgG] or RAM-IgE. At day 0, no differences were seen
in the percentages off-positive and 7[f-double positive B cells
when comparing control mice and IL-4 treated mice. IL-4
treatment had increased the percentage of 71-positive B cells
by 16%. By day 4 the percentage of 71-positive B cells
decreased by 13% when RAM-lgG | was used as antigen. At
the same time the fraction of c-positive B cells in this culture
showed a three-fold increase. Most of these f-positive B cells,
were 7|f-double positive. These results argue for a sequential
switch in these cultures in which 7i-positive B cells, stimulated
by RAM-IgG] and Th2 cells, switch to f-positive B cells with
7(f-double positive B cells as an intermediate stage.
Such sequential switching was not seen for B cells from
control treated mice, indicating that IL-4 is important for the
commitment of B cells to undergo sequential switching. In
cultures in which T cell-depleted spleen cells from control-
treated mice were stimulated with RAM-IgE the percentage
of 7|-positive B cells decreased, but no difference was seen in
the percentage off-positive and 7ie-double positive B cells.
These results suggest that stimulated 'yie-double positive B
Table 2. Isotype levels in the supernatants of secondary T-B cell
cultures in vitro
Control IL-4-treated
Isotype RAM/IgE RAM/IgG, RAM/IgE RAM/IgG,
No IL-4 added to the cultures
IgE(ng/ml) 56 279 217 426
IgG, (/ig/ml) 10 19 II 29
IgG2^{ng/ml) 130 160 183 313
lL-4 (100 IU/ml) added to the cultures
IgE(ng/mI) 147 286 322 406
IgG, (/ig/ml) 13 18 15 25
IgG2a(ng/ml) 96 86 255 175
2.5 X lO '^/ml T cell-depleted spleen cells from control and lL-4-
[reated mice and 5 x 10''/ml irradiated (30Gy) CDC35 cells were
cultured for 5 days in 8 wells of 200/il in the presence of lOng/ml
RAM-IgE or RAM-IgG|. Results represent supernatant levels as
determined by ELISA.
cells differentiate to IgG|- and/or IgE-secreting cells that do
not express sig. and are therefore no longer detectable by flow
cytometry.
•yic-double positive B cells can explain the different cytokine
requirements of memory IgGi ond IgE responses
We have shown in adoptive transfer experiments that
TNP-specific IgG| and IgE memory responses were not
differentially influenced by T cells from control and lL-4
treated mice (Fig. 1). Moreover, it was shown that
7 iedoub le positive B cells can develop both in IgG | -and IgE-
secreting cells in vitro (Fig. 2). Therefore, we next studied the
cytokine dependence of memory B cells to become IgG|- or
IgE-secreting cells in vivo.
To this end, irradiated mice were reconstituted with TNP-
primed spleen cells from control treated mice (Table 4).
Neutralizing the presence of IL-4 by anti-IL-4 MoAb in
these mice did not reduce the production of TNP-specific
IgG| , whereas it did partially reduce the production of TNP-
specific IgE (Table 4). This production of TNP-specific IgE
was 1820-fold higher than the IgE levels found in immunized
non-reconstituted irradiated mice, and is 15% of the
TNP-specific IgE level in reconstituted mice that received
control MoAb, This indicated that the TNP-specific IgE
response after immunization, of irradiated mice reconsti-
tuted with spleen cells from control-treated mice, was at
least in part (15%) IL-4 independent. Using neutralizing
MoAb against IL-5 and IL-6, TNP-specific IgGj and IgE
memory responses were analysed in reconstituted recipient
Table 3. Surface Ig phenotype of B cells in secondary T-B cell
cultures in vitro
Surface Ig (sIg)
e Total 7i€ Total
DayO
Control
IL-4-treated
Day 4
RAM/IgG, stimulation
Control 2
lL-4-treated 9
RAM/IgE stimulation
Control 0
IL-4-treated 4
0 4
2 1
84
100
82
87
87
78
80
99
81
80
86
76
f' = total sIgE ' - 7 , e ; 7,* = total sIgG, ^ - 7 1 * .
Results are expressed as percentages of B220 '' B cells in cultures
with RAM-IgE or RAM-IgG, as stimulating antigen; 2.5 x lOVml T
cell-depleted spleen cells and 5 x 10''/ml irradiated (30Gy) CDC35
cells were cultured in 10 wells of 2ml.
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Table 4. Influence of cytokines on TNP-specific secondary IgG| and IgE responses after adoptive transfer
Treatment
TNP-specific
Day 9 Day 12
TNP-specific IgE
Day 9 Day 12
Control
+ aIL-4
+ QIL-4 + aIL-5
+ aIL-4 + alL-6
+ aIL-5 + cilL-6
+ alL-4 + QIL-5 + QIL-6
Irradiation control
2847 ± 333
1376 ±293
2183 ± 554
1934 ±513
1483 ± 150
1593 ± 286
66 ± 12
6720 ± mi
5366 ± 584
4127 ± 1070
3999 ± 463
2553 ± 362
2332 ± 361
35 ± 0
87.6 ± 14
4.5 ± I.O
8.5 ± 0.4
6.6 ± 1.0
92.8 ± 8.9
]IO.4± 12.4
0.015 ±0.011
61.9 ±67
9.1 ± 1.7
12.4 ± 1.5
5.8 ± 0.7
65.0 ± 7.7
57.1 ± 7.2
0.005 ± 0.001
Irradiated mice {6Gy) were reconstituted with 1 x 10^  TNP-KLH primed spleen cells from control-treated mice. Antibody treatment:
control(GLl 13,4mg/mousei.p.);aIL-4(lIBM. 10mg/mousei.p.);aIL-5(TRFK-5,2mg/mousei.p.),andaIL-6(20F3, 2mg/mouse i.p.). All
reconstituted mice were boosted with 10/ig TNP-KLH adsorbed on alum i.p. Results are represented in/ig/ml as arithmetic mean ± SEM
(n = 5).
mice. The TNP-specific IgE memory responses turned out to
be IL-5- and IL-6-independent, whereas the TNP-specific
IgG I production was markedly decreased after these
treatments.
Moreover, these results also suggest an additive IL-5 and
IL-6 dependence of the TNP-specific IgGi production during
memory responses. In the presence of these neutralizing
antibodies the complete TNP-specific IgE response was IL-
4-independent. This may indicate that 71-positive and/or 71c-
double positive TNP-specific memory B cells, that are
blocked to differentiate to IgG 1-secreting cells in the absence
of IL-5 and IL-6 [18], can develop in IgE-secreting cells
independently from IL-4.
As it was shown that IL-4 can commit B cells to undergo
sequential isotype switching, by which 7ie-double positive
cells are formed, we also examined the cytokine requirement
of TNP-specific memory B cells from IL-4-treated mice for
production IgG| and IgE. As stated before, no differences
were seen in the percentages of splenic T and B cells between
control- and IL-4-treated mice at this point. It was found that
even prolonged IL-4 treatment for 4 months after primary
immunization did not induce differences in the cytokine
dependence of the TNP-specific memory B cells generated
(Table 5). IL-4 treatment reduced the generation of TNP-
specific IgG) and IgE memory cells, but no differences were
seen in the cytokine requirement for secondary TNP-specific
IgGi and IgE responses in irradiated recipient mice recon-
stituted with either spleen cells from control or IL-4-treated
mice. These results indicate that IL-4 treatment did not
induce intrinsic changes in the TNP-specific memory B cells
with respect to their cytokine dependence.
Memory B cells are less dependent on IL-4 and resistant to
IFN-y when becoming IgE-seereting cells in vivo
To more fully determine the role of cytokines in a non-
adoptive transfer model, we immunized naive mice and
mice primed 3 months previously with TNP-KLH during
which either IL-4 was neutralized, or IFN-7 administered.
The effect of neutralizing IL-4 on TNP-specific memory IgE
responses has already been described [22], although in that
study mice were boosted already 3 or 6 weeks after priming.
However, for IFN-7 comparable studies were not described.
Immunization of mice with 10/ig TNP-KLH resulted in a
primary TNP-specific IgE response starting at a level
<^0.03/ig/ml at day 0 and reaching a level of 0.
Table 5. EfFect of prolonged IL-4 treatment on the cytokine
dependence of TNP-specific memory B cells
Days after transfer
Treatment 12
TNP-specific IgG,
Control 130 ±22
+ oIL-4 77 ± 20
+ aIL-5 + olL-6 79 ± 12
+ QIL-4 + QIL-5 + aIL-6 72 ± 10
925 ± 348 1612 ±394
515 ± 101 1949 ±379
517 ± 74 808 ± 123
493 ±71 609 ±87
TNP-specific IgE
Control
+ Q1L-4
+ QIL-5 + aIL-6
7.0 ± 1.7 33.4 ±6.8 14.6 ± 1.6
0.2 ±0,04 2,7 ±0.6 4.0 ± 1.2
2.9 ±0.7 33.8 ± 7.7 20.1 ±2.5
+ nIL-4 + QIL-5 + «IL-6 3.6 ± 1.5 29.0 ± 7.8 17.2 ± 4.5
Irradiated mice (6 Gy) were reconstituted with 1 x 10^  TNP-KLH
primed spleen cells from IL-4-treated mice. Antibody treatment:
control (GLl 13, 4mg/mouse i.p.); QIL-4 (llBl I, lOmg/mouse i.p.);
QIL-5 { T R F K - 5 . 2mg/mouse i.p.), and QIL-6 (20F3. 2mg/mouse
i,p,). All reconstituted mice were boosted with 10//g TNP-KLH
adsorbed on alum i.p. Results are represented in/jg/ml as arithmetic
mean ± SEM (n = 5).
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control anti-IL-4
Fig. 3. Effect of anti-IL-4 and IFN-7 on (A) the primary and (B)
the secondary TNP-specific IgE response. Mice were primed and
boosted with lO i^g TNP-KLH adsorbed on alum, followed by
either a control, anti-lL-4 or IFN-7 treatment as described in the
Materials and Methods section. Serum levels of TNP-specific IgE
are expressed as arithmetic mean ± SEM {n = 5).
at day 14. This increase could be blocked cotnpletely by
neutralizing IL-4, indicating the IL-4 requirement of the
primary TNP-specific IgE response. This anti-IL-4 treatment
was more efficient in blocking the TNP-specific IgE response
than was IFN-7 which inhibited the response up to 27%
(Fig. 3A). On the other hand, the secondary IgE response
could only be inhibited up to 24% at day 7 by treatment with
anti-IL-4, suggesting a partial IL-4 independence of this
response (Fig. 3B). TNP-K.LH immunization in combina-
tion with a control treatment gave rise to 5.1/ig/ml TNP-
specific IgE at day 7 as compared to 1.2^g/mi that occurred
in the presence of anti-IL-4. Moreover, this secondary TNP-
specific IgE response could not be inhibited to any significant
extent by IFN-7 treatment (Fig, 3B), pointing to the minor
role that IFN-7 plays during the secondary IgE response.
DISCUSSION
In this paper we show that the effects of prolonged IL-4
treatment during memory formation after priming with TNP-
KLH, that we have previously described [19], are primarily
mediated at the B cell level, leaving the T cells unchanged.
Major changes occur in the 7ie-double positive B cell
population which is increased significantly as a result of
IL-4 treatment. Moreover, in vitro T-B cell cultures in
which primed B cells were stimulated in an isotype-specific
manner by rabbit anti-mouse isotype antibodies and a rabbit
Ig-specific Th2 cell clone suggested the existence of a 7if-
double positive B cell population that can develop into both
IgG]- and IgE-secreting cells.
The number of B cells switched to IgGi and IgE increased
in vivo as a result of prolonged IL-4 treatment. This was
found both at the membrane level and by stimulating B cells
in vitro, independently of their antigen specificity, but isotype-
specifically with rabbit anti-mouse isotype-specific anti-
bodies, that were tested extensively for isotype specificity,
and a rabbit Ig-specific Th2 cell clone. Moreover, it was found
that upon stimulating 71-positive cells. IgE-secreting cells
could be detected on day 5 of culture. These IgE-secreting
cells can either originate from 71-positive cells that have
undergone sequential isotype switching [2, 24], or can be the
result of pre-existing 7tf-double positive B cells [25] that
differentiate to IgE-secreting cells after stimulation. When f-
positive B cells are i so type-specifically stimulated, both IgG|-
and IgE-secreting cells are found. The latter are most
probably the result of 7|f-double positive cells that have the
ability to differentiate either into IgGr or IgE-secreting cells.
These results imply that B cells exist that express IgE on their
membrane, but have not yet undergone sequential isotype-
switching. Moreover, they show that these B cells can be
stimulated via this membrane IgE to develop in IgG|-secret-
ing cells. Another possibility could be that these 7if-double
positive B cells, upon stimulation, can develop in cells that
cosecrete these isotypes, for which evidence has been pre-
sented by Mandler et al. [24]. In all cases more IgGr and IgE-
secreting cells per culture were found after culturing T cell
depleted spleen cells of IL-4 treated mice than upon culturing
T cell depleted spleen cells of control treated mice. These
results are not caused by anti-Ig activity of the rabbit anti-
mouse isotype specific antibodies used, because opposite
effects were found upon cutturing with RAM-lgG2a'2b as
antigen. It has been described by Snapper et al. that Thy-1
positive B cells are highly enriched in IgE-secreting cells [41].
In this study we stimulated Thy-1-depleted spleen cells and
determined the number of B cells that became lgG|- and IgE-
secreting cells. Therefore, Thy-1 depletion will not influence
the numbers of IgE-secreting cells that were found as result of
stimulation. In fact, Thy-1 depletion could have had a
positive effect in lowering the background levels of cells
that already secrete IgE independent of specific stimulation.
FACScan analysis revealed that, upon IL-4 treatment, the
pool of 7if-double positive cells is profoundly increased in
vivo at days 2 and 3 after IL-4 administration. On the other
hand, no major changes occurred in the pool of e-single positive
B cells after IL-4 treatment, suggesting that the effect pre-
viously found, that IL-4 increased the total IgE serum levels
[19], was mediated by increasing the pool of 7if-double
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positive B cells. The results of both the in vitro T-B cell
culture system and the in vivo adoptive transfer experiments
provide evidence for such double positive B cells from which
IgE-secreting cells originate, through the sequential isotype
switching which has been reported by Yoshida et al. [2]. These
authors provided molecular evidence for a sequential class
switching from // to e via 71 [2]. This could explain why,
during the process of switching to IgE in the LPS system,
75yo of the e-positive B cells co-express 71, representing 9%
of the total B cell population [25]. In our study further
evidence is provided for such a sequential class switching,
detectable at the membrane level. When selectively stimu-
lated, isotype-specifically via 71, with a rabbit Ig-specific Th2
clone and RAM-lgGj antibody as antigen, the number of 71-
positive splenic B cells decreased, while there was an increase
in the percentage of 7ie-double positive B cells from 1 to 7%
of all B22O' B cells. This was only seen when B cells were
obtained from mice that were repeatedly treated with IL-4.
We therefore conclude that IL-4 commits 71-positive B cells
to undergo a sequential switch to c-positive B cells. However,
it is also possible that IL-4 increases B cell populations,
resulting in the possibility of detecting sequential isotype
switching at the membrane level. A successive DNA deletion
could explain the simultaneous expression of slgGj and sIgE,
if the 7i mRNA expression is stable and functional even after
the switch to f. Other mechanisms which allow the existence
of 7 |f-doub!e positive cells are the alternative splicing of long
nuclear RNA and trans-splicing [42]. In both mechanisms,
switching occurs without DNA recombination.
When studying lipopolysaccharide-activated murine B
cells, IL-4-induced IgE class switching occurred predomi-
nantly through sequential isotype switching [24]. In this
system it was also shown that LPS stimulation in the
presence of IL-4 resulted in 7]e-double positive cells that
could produce IgGj as well as IgE. Recently, evidence for a
successive class switching was reported in the human system
by comparing S^-Se junctions in IL-4 treated human B
lymphoblastoid cells [43]. These composite switch regions
contained S7 sequences, indicating that sequential switching
had occurred. The data presented in our study show that
sequential isotype switching is also likely to occur during
secondary responses. It is shown that 71-positive primed B
cells upon stimulation develop in 7ie-double positive B cells
that can differentiate in both lgG|- and IgE-secreting cells.
The fact that memory B cells can undergo sequential
isotype switching makes it possible that they are not tightly
controlled by T cells. This could be the reason that the TNP-
specific IgGi and IgE responses in irradiated control mice are
not influenced by using T cells from control or IL-4 treated
mice. Using an adoptive transfer system, we studied the
cytokine dependence of TNP-specific secondary IgG, and
IgE responses. Such a system was chosen, because it is known
that secondary IgE responses are preferentially enhanced
after transferring spleen cells in irradiated control mice [19,
44). It was found that IL-5 and IL-6 were necessary for
maximum in vivo TNP-specific IgG| responses. IL-4 treat-
ment during the primary response did not change this
cytokine dependence. These results, with respect to IgGi,
are in line with the observation that IL-4 can induce mem-
brane bound IgG] on B cells, whereas IL-2 and IL-5 are
necessary for subsequent IgGj secretion [45]. By using the
adoptive transfer system it was clearly shown that the TNP-
specific secondary IgE response is partially lL-4-independent
in that it could not be completely inhibited by neutralizing
antibodies against IL-4. This IL-4-independent IgE level is
even higher than the IL-4 independent IgE response in
boosted mice (Eig. 3B). Surprisingly, in the absence of IL-5
and IL-6 no inhibition of the secondary TNP-specific IgE
response by anti-IL-4 MoAb was detectable. A possible
explanation for these results is that TNP-specific IgG|
memory B cells do not mature to IgGi-secreting plasma
cells in the absence of IL-5 and IL-6. since these two
cytokines are likely to be involved in this process [16- 18].
The 7|-positive, or 7|C-double positive B cells that are
arrested could subsequently switch to become f-positive B
cells for which they need less IL-4, or eventually can switch
independently of the presence of IL-4. These B cells do not
appear to be dependent on IL-5 and IL-6 to become IgE-
secreting cells [18]. Other factors that induce or potentiate
secretion of IgE, like IL-13in the human system [46]. and that
are not analysed in our study could be involved in the
development of IgE-secreting cells, Although it has not yet
been ascertained that IL-13 induces IgE secretion by mouse B
cells, this might be possible under certain circumstances.
Recently, it has been described that neutralizing anti-IL-4
antibodies, when complexed with IL-4, can serve as reservoirs
for long-term (at least 9 days) delivery of cytokines in vivo
[47]. It is possible that, in the absence of lL-5 and lL-6. a
persistent low dose of IL-4, as a result of IL-4-anti-IL-4
complexes, is sufficient to allow differentiation of 71-positive
and/or 7if-double positive B cells in IgE-secreting cells. The
presence of additional IL-4 in combination with neutraliza-
tion of IEN-7 did not increase the TNP-specific secondary
IgG| and IgE response (data not shown). This indicates that
the endogenous production of IL-4 was already sufficient to
result in a maximum response in irradiated mice reconstituted
with spleen cells from control treated mice.
We next studied the dependence on IL-4 and the suscep-
tibility to IFN-7 of primary and secondary TNP-specific IgE
responses. With respect to IFN-7, no studies have been
described in which its role in memory IgE responses is
established. We found that the primary TNP-specific IgE
response is completely IL-4-dependent and can be inhibited
extensively by IFN-7, whereas the secondary TNP-specific
IgE response is partially IL-4-independent, and cannot be
inhibited by IEN-7 in a concentration that does inhibit the
primary TNP-specific IgE response. The IL-4-independent
part of the IgE response is probably the result of memory B
cells already switched to IgE, whereas the IL-4-dependent
component can result from B cells switched to IgGi, which
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need IL-4 to switch further to IgE. Finkelmanera/. described
that memory IgE responses for TNP-KLH are. like primary
responses, dependent on IL-4 [22]. This discrepancy with our
results is most probably the result of the different resting
periods between priming and boosting used in these studies.
Using sheep red blood cells as (hymus dependent antigen it
was found that the maximum memory formation for IgG|
was achieved only 12 weeks after priming [48]. It is quite
possible that during the 3 weeks after priming, memory B cells
switched to IgE are not formed to an extent that allowed
detection of IgE in the absence of IL-4.
Overall, these results make clear that sequential isotype
switching not only plays an important role in the generation
of primary, but also in secondary IgG| and IgE responses.
Such sequential isotype switching, most probably, causes the
differences in cytokine requirements that are observed when
examining the capacity of unprimed naive B cells versus
memory B cells to become IgGr or IgE-secreting cells.
Furthermore, it is shown that in vivo also the IgE-inducing
capacity of lL-4 is mediated through the generation of 7if-
double positive cells, that can be stimulated to become both
IgGr and IgE-secreting cells.
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